Health Systems

More from the Series

BRIEF

Tackling the Triple Transition in Global Health Procurement (brief)
Rachel Bonnifield et al.
July 02, 2019
There have been impressive gains in global health over the past 20 years, with millions of lives saved through expanded access to essential medicines and other health products. But behind these successes is an unacceptable reality: in many low- and middle-income countries, lifesaving health products...
CGD NOTE

Modicare Post-Election: Recommendations to Enhance the Impact of Public Health Insurance on UHC Goals in India

Kalipso Chalkidou et al.
May 11, 2019
Hailed as one of the largest publicly funded health insurance programs in the world, India’s “Modicare” has, since its launch a little more than six months ago, made universal healthcare coverage an election theme for the first time in the country’s history. 
WORKING PAPER

Who Benefits from Pharmaceutical Price Controls? Evidence from India - Working Paper 509
Emma Boswell Dean
April 23, 2019
With the goal of driving down drug costs, governments across the globe have instituted various forms of pharmaceutical price control policies. In this paper, we examine the theoretical and empirical effects of one implementation of pharmaceutical price controls, in which the Indian government placed...

The Future of Global Health Procurement: Background Research
Amanda Glassman
et al.
April 15, 2019
Background research and resources from CGD's growing porfolio on the future of global health procurement.